HER2 inhibitors in the management of HER2-positive extramammary Paget's disease: a literature review
{{output}}
Extramammary Paget's disease (EMPD) is a rare malignant adenocarcinoma with a poor prognosis when invasive or metastatic, and no standardized care when inoperable. One-third of EMPDs overexpress HER2/ERBB2 (human epidermal growth factor receptor 2), highlight... ...
